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Abstract
We report a case of a 52-year-old patient with dilated cardiomyopathy who presented with worsening heart failure.
Two-dimensional transthoracic echocardiography and real-time three dimensional transthoracic echocardiography
showed severe dilated cardiac chambers, impaired ejection fraction and a mobile right atrial thrombus 2.6 × 1.0
cm in size, traversing the right atrial cavity during the whole cardiac cycle. After one week therapeutic
anticoagulation, echocardiography confirmed no evidence of residual thrombus.
Keywords: Thrombus Dilated cardiomyopathy, Echocardiography
Introduction
Dilated cardiomyopathy (DCM) is a kind of malignant
cardiac disorder, which affects 5 in 100,000 adults and
0.57 in 100,000 children [1,2]. It represents a poor long-
term prognosis with the mortality rate is 70% to 80% at
eight years for most patients who undergo heart failure
[3]. Right heart thrombus presents higher mortality [4]
with a risk of pulmonary embolization [5], which has
been found in patients with DCM rarely. Echocardiogra-
phy plays a pivotal role in the evaluation of DCM and
intracardiac masses. To the best of our knowledge, this
is the first case report using combination of two-dimen-
sional echocardiography and real-time three dimensional
echocardiography in the assessment of right atrial
thrombus happened in DCM.
Case presentation
A 52-year-old man (body surface area: 1.3 m
2) known to
have dilated cardiomyopathy (DCM), was admitted for
worsening heart failure (NYHA class IV). He presented
with a 5-month history of cough, progressive dyspnoea,
orthopnea and recurrent upper abdominal pain started
from 2 months ago. On examination his vital signs were
body temperature 37°C, blood pressure 80/40 mmHg,
respiratory rate 24 breaths per minute, and electrocar-
diogram showed atrial fibrillation with heart rate 50
beats per minute. Physical examination revealed the
jugular venous distension, significant tender hepatome-
galy and bilateral pitting edema at lower limbs. Labora-
tory tests showed elevated pro-NT brain natriuretic
peptide of 22145 pg/ml (normal 0 to 227 pg/ml) and
unremarkable D-dimer. X-ray and computed tomogra-
phy of the chest demonstrated consolidation of bilateral
lower lobes with pleural effusion, while his venous Dop-
pler of lower extremities was normal. Based on his clini-
cal condition, echocardiography was immediately
inserted. There were severe dilated cardiac chambers,
especially enlargement of the left ventricle (LV) (58
mm/m2) with spherical shape, decreased wall thickness,
impaired ejection fraction 22% and severe mitral regur-
gitation on two-dimensional transthoracic echocardio-
graphy (2DTTE). Parasternal short axis and subxyphoid
view (Figure 1) showed the mobile right atrial mass
highly suspicious of a thrombus traversing the right
atrial cavity during the cardiac cycle accompanying with
free-floating small parts of the thrombi. Real-time three
dimensional transthoracic echocardiography (RT-
3DTTE) was performed to further confirm the nature of
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contour, measured 2.6 × 1.0 cm which floating around
the orifice of inferior vena cava and protruding into the
right atrial cavity (Figure 2). In addition, RT-3DTTE
evaluated right ventricle (RV) systolic dysfunction with
ejection fraction 15.7% (Figure 3). He was maintained
on digoxin, spironolactone, furosemide, sotalol and
dopamine. At the same time therapeutic anticoagulation
was started with low-molecular-weight heparin and war-
farin. The patient had an uneventful hospital course and
one week follow-up echocardiography confirmed ade-
quate removal of the thrombus (Figures 4A and 4B).
Discussion
DCM is a multifactorial myocardial disease character-
ized by enlarged left or whole heart chambers and
decreased heart function [6]. Symptoms of progressive
heart failure are common in patients with dilated cardi-
omyopathy and endstage disease may predispose to
arrhythmia associated with a high risk of thrombus for-
mation which may lead to thromboembolic events [7].
Right heart thrombus happens about 4-18% cases with
acute pulmonary embolism [8,9], while rare found in
patients with DCM. They may develop within right
heart because of atrial fibrillation, hypercoagulable state
caused by disease or origin from peripheral venous clots
due to bedridden condition that temporarily embolized
to the right heart. This type of thrombus presents higher
mortality [4] with a risk of potential fragmentation and
causing massive pulmonary embolization [5].
Echocardiography is the most important non-invasive
comprehensive method in clinical diagnosis of DCM as
well as evaluating intracardiac masses or thrombi. In
our report, the patient had a right atrial mass with the
severity of both ventricle dysfunctions. Although
Figure 1 A mass of right atrium: A) Parasternal short axis view by 2D TTE, B) Subxyphoid view by 2D TTE.
Figure 2 Mobile mass of right atrium: RT-3DTEE shows a 2.6 ×
1.0 cm homogeneously echogenic mobile mass which floating
around the orifice of inferior vena cava and protruding into the
right atrial cavity (arrow).
Figure 3 Right ventricular ejection fraction: RT-3DTEE measured
right ventricular systolic dysfunction with an EF 15.7%.
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ture, function and assess the hemodynamic effects, the
RT-3DTTE adds valuable benefits as follows: (1) the
RT-3DTTE can provide complete information of intra-
cardiac masses[10] including size, shape, consistency,
mobility and location that in relation to cardiac anato-
mical structures.(2) It allows us to differentiate the
thrombus from other masses (e.g. cardiac tumors, vege-
tations) by revealing lobula, stalk, hyperechogenicity or
hypoerechogenicity and spatial relationship with adja-
cent structures, which may help in demonstrating prog-
nostic indications or the response to treatment.(3) In
addition, RV dysfunction plays an important role in
adverse outcome [11], RT-3DTTE provides a practical
approach for quantified the RV function without relying
on the geometric assumptions. (4) Patients with DCM
usually have distorted LV shape. RT-3DTTE can quan-
tify the LV function without long time breath holding
and fully cooperative, also the result is more accurate
even like as MRI technology [12]. In our presentation,
the combination of 2DTTE and RT-3DTTE may facili-
tate the diagnosis in evaluating heart function and char-
acterize the nature of thrombus better.
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